The Latest Breaking News from Mangeet Kaur BounsMangeet

ChargePoint Holdings: Buy or Sell in 2023?

EV charging company ChargePoint (CHPT) fell short of its revenue guidance in the last reported quarter and expects slower revenue growth ahead. The stock has plummeted more than 45% over the past year, with investors becoming increasingly concerned about its mounting losses and lousy revenue guidance. Given a challenging macro…

StockNews.com · Mar 23, 2023

GME Stock: Is It Time to Buy or Sell?

Video game and electronics retailer GameStop (GME) reported declining revenue and huge losses in its last reported quarter, and its financial position is threatened by increasing cash burn. However, following last year’s massive losses, this meme stock recovered slightly earlier this year. Let’s find out if one should buy or…

StockNews.com · Mar 21, 2023

The Best Tech Stock to Buy Now for Under $5

Despite a challenging macro environment, networking and telecom equipment maker Nokia (NOK) delivered a solid financial performance last year and is well-positioned for robust growth in 2023 and beyond, driven by the sustained demand for its offerings and continued optimization of its portfolio with strategic launches, partnerships, and investments. Hence,…

StockNews.com · Mar 20, 2023

Is Disney a Good Stock to Buy Right Now?

Entertainment giant Walt Disney (DIS) recently notched its 52-week low of $84.07. The stock is expected to be on a downward trajectory as the company grapples with higher streaming expenses, fears of declining consumers’ discretionary spending, and other macroeconomic headwinds. However, given DIS’ solid revenue growth in the first quarter…

StockNews.com · Mar 13, 2023

Is It Time to Hit the Brakes on Mullen Automotive?

Automotive maker Mullen (MULN) generated no revenue but incurred huge losses since its debut in late 2021. Shares of MULN have plummeted more than 80% over the past year due to dampened investor sentiment amid deteriorating financials, continued share dilution, and macro headwinds. Given the challenging macro environment, should investors…

StockNews.com · Mar 10, 2023

1 Software Stock That's Worth Its High Price

Software giant Adobe (ADBE) continues to grow and retains a strong position in the software space, supported by strong demand for its offerings and continued innovation. Although ADBE is trading at a premium price, this software stock still has enough upside left. Continue reading….

StockNews.com · Mar 9, 2023

Should You Buy or Sell This Popular Software Stock in 2023?

Financial technology company Robinhood’s (HOOD) shares are currently trading more than 40% below their 52-week high due to dampened investor sentiment amid mounting losses, a shrinking active user base, and growing regulatory pressures. Given HOOD’s massive popularity among young and first-time traders, let’s find out if this financial software stock…

StockNews.com · Mar 7, 2023

1 High-Quality Stock to Buy Now for the Long Term

Payments technology giant Visa (V) reported better-than-expected revenue and earnings in the first quarter of fiscal 2023. Furthermore, analysts are bullish about the company’s long-term prospects, driven by the growing use of digital payments and a surge in e-commerce worldwide. Hence, investors could consider buying and holding this high-quality stock…

StockNews.com · Mar 6, 2023

3 Cannabis Stocks to Avoid Like the Plague in March 2023

The cannabis industry faced several challenges last year, including overproduction amid high inflation weighing on overall demand. With growing concerns over rising inflation and a looming recession, the industry is expected to remain under immense pressure this year. So, it could be wise to avoid fundamentally weak cannabis stocks Tilray…

StockNews.com · Mar 6, 2023

1 Resilient Growth Stock to Buy Now and Hold Forever

Biopharmaceutical giant Gilead Sciences’ (GILD) shares have risen nearly 30% over the past year despite lingering macroeconomic challenges. Moreover, the company delivered solid growth last year and is expected to maintain its business momentum in 2023 and beyond, driven by its diversified medicines portfolio. Hence, investors could consider buying and…

StockNews.com · Mar 3, 2023